{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:08:57Z","timestamp":1773047337964,"version":"3.50.1"},"reference-count":10,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T00:00:00Z","timestamp":1236038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Several studies have suggested that recombinant factor VIIa (rFVIIa) is effective and safe at doses &gt;90\u2003\u03bcg kg<jats:sup>\u22121<\/jats:sup>. In March 2007, the European Medicines Agency approved the use of single\u2010dose rFVIIa 270\u2003\u03bcg kg<jats:sup>\u22121<\/jats:sup> for the treatment of mild\u2010to\u2010moderate bleeds in haemophilia patients with inhibitors. The aim of this study was to describe the use of single\u2010dose rFVIIa in a real\u2010life setting. In November 2007, seven haemophilia specialists from five European countries convened to share and discuss their experiences with the single\u2010dose rFVIIa regimen within haemophilia A. Case histories of eight patients were discussed in this retrospective study. Six adult and two paediatric patients (age range, 19\u2003months\u201340\u2003years) were treated with single\u2010dose rFVIIa for a variety of target\u2010joint bleeding, other bleeds and bleeding prevention. Treatment was successful in all the eight cases, with most patients requiring one dose to achieve bleeding resolution. No thrombotic or other safety concerns were raised by single\u2010dose rFVIIa treatment. All patients and physicians preferred single\u2010dose rFVIIa treatment to multiple injections; key benefits of single\u2010dose rFVIIa treatment reported by patients and physicians included improved quality of life, greater convenience and ease of administration, improved compliance, faster control of bleeding, less injection\u2010related pain and faster pain relief. In the patients reported here, single\u2010dose rFVIIa 270\u2003\u03bcg kg<jats:sup>\u22121<\/jats:sup> appears to be an effective and safe haemostatic treatment that improves the quality of life and convenience of treatment for patients. Such treatment might be of particular benefit for patients with difficult venous access or needle phobia.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2008.01968.x","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T01:57:34Z","timestamp":1236131854000},"page":"760-765","source":"Crossref","is-referenced-by-count":18,"title":["Single\u2010dose (270\u2003\u03bcg kg<sup>\u22121<\/sup>) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres"],"prefix":"10.1111","volume":"15","author":[{"given":"B.","family":"PAN\u2010PETESCH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"LAGUNA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"MITAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"STANLEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"TORCHET","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Z.","family":"SALEK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"SALAJ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,21]]},"reference":[{"key":"e_1_2_8_2_2","unstructured":"NovoSeven\u00aeSummary of Product Characteristics. Available at:http:\/\/emc.medicines.org.uk\/emc\/assets\/c\/html\/displayDocPrinterFriendly.asp?documentid=1367. (last accessed on 9 May 2008)."},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615388"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00059.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01075.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH05-07-0510"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01772.x"},{"key":"e_1_2_8_8_2","unstructured":"DargaudY BordetJC LienhartA NegrierC.Tailoring of NovoSeven\u00aeinfusions to individual patients\u2019 needs. Novo Nordisk Symposium Barcelona November2007."},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2005.11.006"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01601.x"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2008.03.007"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2008.01968.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2008.01968.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:07:05Z","timestamp":1697242025000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2008.01968.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,21]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1365-2516.2008.01968.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01968.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,21]]}}}